
SK bioscience joins KDCA project to develop cell-cultured bird flu vaccine
SK bioscience said Tuesday it has been selected for the Korea Disease Control and Prevention Agency's (KDCA) project to develop a bird flu vaccine, as the disease is highly likely to trigger the next pandemic. SK bioscience is the only company in Korea …